CEO (Chief Executive Officer) since 2001
Partner/Owner since 1990
Representative before the EPO

Employment test 51 - 200 employees
Company dna potter clarkson llp
operating since 1889
Headquarter in Nottingham and 1 office
active in Legal Services, IP Consulting, and IP Portfolio Processing

We have observed 8 EP applications Richard Bassett has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after September 09, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP12770817

SELECTIVE CYSTEINE PROTEASE INHIBITORS AND USES THEREOF

IPC classification:
C07K 7/06, C07K 5/08, C07K 5/06, C07K 5/02, C07K 5/00
Agent:
Richard Bassett, Potter Clarkson LLP
Status:
The patent has been granted
EP12785983

PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME VIRUS RESISTANT ANIMALS

IPC classification:
A01K 67/027, C12N 15/00
Applicant:
University Of Missouri
Agent:
Richard Bassett, Potter Clarkson LLP
Status:
EXAMINATION IN PROGRESS
EP12728887

MODIFIED ALGINATES FOR CELL ENCAPSULATION AND CELL THERAPY

IPC classification:
A61K 47/00, C40B 50/00, C08B 37/00
Applicant:
Massachusetts Institute of Technology (MIT) Inc.
Agent:
Richard Bassett, Potter Clarkson LLP
Status:
GRANT OF PATENT INTENDED
EP12725992

THERAPEUTIC PROTEINS WITH INCREASED HALF-LIFE AND METHODS OF PREPARING SAME

IPC classification:
A61K 47/48, A61K 38/55, A61K 38/38
Applicant:
Baxalta Incorporated
Applicant:
Baxalta GmbH
Applicant:
Baxter Healthcare SA
Applicant:
Baxter International Inc
Agent:
Hoffmann Eitle PartmbB
Agent:
Richard Bassett, Potter Clarkson LLP
Status:
GRANT OF PATENT INTENDED
EP12728341

BIOADHESIVE DRUG DELIVERY COMPOSITIONS

IPC classification:
A61K 9/48
Agent:
Richard Bassett, Potter Clarkson LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12731234

SYNTHESIS AND CHARACTERIZATION OF SECOND GENERATION BENZOFURANONE RING SUBSTITUTED NOSCAPINE ANALOGS

IPC classification:
A61K 31/4355, C07D 491/04, A61P 35/00
Applicant:
Georgia State University Research Foundation, Inc.
Agent:
Richard Bassett, Potter Clarkson LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12815580

CARBOCYANINES FOR G-QUADRUPLEX DNA STABILIZATION AND TELOMERASE INHIBITION

IPC classification:
C12Q 1/68
Applicant:
Georgia State University Research Foundation, Inc.
Agent:
Richard Bassett, Potter Clarkson LLP
Status:
EXAMINATION IN PROGRESS
EP15171701

CROSSLINKED CATION EXCHANGE POLYMERS, COMPOSITIONS AND USE IN TREATING HYPERKALEMIA

IPC classification:
A61P 1/00, A61K 31/74
Agent:
Richard Bassett, Potter Clarkson LLP
Agent:
Eisenführ Speiser & Partner Patentanwälte Rechtsanwälte PartGmbB
Status:
EXAMINATION REQUESTED

Please Sign in to use this feature